IGF2 and hepatocellular carcinoma: Moreover, Ma et al. demonstrated that IGF2 BP3 promotes HCC progression by modulating the phenotypes of macrophages and CD8 + T cells within the tumor microenvironment, further illustrating the interplay between oncogenic signaling and immune regulation in HCC [9].